LifeStance Health Group (NASDAQ:LFST) Reaches New 1-Year High – Should You Buy?

Posted by Brian Himes on Sep 2nd, 2026

LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $13.15 and last traded at $12.8750, with a volume of 382671 shares changing hands. The stock had previously closed at $12.60.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on LFST shares. Canaccord Genuity Group increased their price target on LifeStance Health Group from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. The Goldman Sachs Group started coverage on LifeStance Health Group in a research report on Friday, June 5th. They issued a “neutral” rating and a $9.00 price objective for the company. Wall Street Zen upgraded LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 15th. Barclays increased their target price on LifeStance Health Group from $9.00 to $13.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. Finally, BTIG Research lifted their price target on LifeStance Health Group from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $12.38.

Get Our Latest Research Report on LifeStance Health Group

LifeStance Health Group Stock Up 1.8%

The stock has a fifty day moving average of $11.32 and a two-hundred day moving average of $8.69. The stock has a market cap of $4.98 billion, a price-to-earnings ratio of 98.87 and a beta of 1.22. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18.

LifeStance Health Group (NASDAQ:LFST – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The business had revenue of $435.35 million for the quarter, compared to analyst estimates of $414.58 million. During the same period in the previous year, the company posted ($0.01) EPS. The company’s revenue was up 26.1% compared to the same quarter last year. As a group, analysts predict that LifeStance Health Group, Inc. will post 0.16 EPS for the current fiscal year.

Insider Buying and Selling at LifeStance Health Group

In related news, COO Lisa K. Miller sold 47,912 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.85, for a total transaction of $519,845.20. Following the transaction, the chief operating officer owned 281,289 shares in the company, valued at approximately $3,051,985.65. The trade was a 14.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.62, for a total value of $144,890,858.34. Following the completion of the sale, the insider owned 98,101,407 shares of the company’s stock, valued at approximately $1,041,836,942.34. This represents a 12.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 14,629,850 shares of company stock worth $154,952,012. 3.50% of the stock is currently owned by insiders.

Institutional Trading of LifeStance Health Group

Several large investors have recently bought and sold shares of LFST. Larson Financial Group LLC boosted its stake in shares of LifeStance Health Group by 19,952.6% in the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock valued at $27,000 after purchasing an additional 3,791 shares during the period. KBC Group NV acquired a new position in LifeStance Health Group in the 1st quarter worth $29,000. EverSource Wealth Advisors LLC boosted its position in LifeStance Health Group by 359.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock valued at $44,000 after buying an additional 5,404 shares during the last quarter. PNC Financial Services Group Inc. boosted its position in LifeStance Health Group by 615.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after buying an additional 7,987 shares during the last quarter. Finally, Assetmark Inc. grew its stake in shares of LifeStance Health Group by 17.0% during the first quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after acquiring an additional 1,367 shares in the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

(Get Free Report)

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.